SCIENTURE HOLDINGS, INC. Total Long-Term Debt
SCIENTURE HOLDINGS, INC. (SCNX) had Total Long-Term Debt of $2.00 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2026-03-30
- 2025-09-30: Long-term Debt $2.00M.
- 2025-06-30: Long-term Debt $3.58M.
- 2025-03-31: Long-term Debt $3.09M.
- 2024-12-31: Long-term Debt $2.90M.
| Period end | Long-term Debt |
|---|---|
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $3.58M 10-Q · filed 2025-08-12 |
| 2025-03-31 | $3.09M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $2.90M 10-K · filed 2026-03-30 |
| 2019-12-31 | $225.00K 10-K · filed 2020-03-30 |
| 2018-12-31 | $522.05K 10-K · filed 2019-03-22 |
| 2017-12-31 | $666.52K 10-K · filed 2018-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |